MedPath

Radiofrequency in Female Pattern Hair Loss

Not Applicable
Conditions
Female Pattern Baldness
Interventions
Other: Vivacy
Registration Number
NCT05409755
Lead Sponsor
Cairo University
Brief Summary

Pattern hair loss, also called androgenetic alopecia (AGA) is considered the most common cause of hair loss in both males and females affecting approximately 85% of males and 50% of females over 50 years of age.

Detailed Description

RF (Radiofrequency) based devices have also been shown to be successful in promoting hair growth, thought to occur through the induction of growth factors in the papillary dermis. Studying the effect of fractional needling radiofrequency in the treatment of female pattern hair loss will pave the way for more treatment options for this common disease.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Patients with female pattern hair loss
Exclusion Criteria
    • Pregnancy and lactation.
  • Bleeding tendency.
  • Cases who received treatment (systemic or topical) in the last 3 months before treatment.
  • Scarring alopecia.
  • Other associated causes of alopecia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MinoxidilVivacyTopical drug
Fractional microneedling radiofrequency followed by minoxidil applicationVivacyDevice and drug
Fractional microneedling radiofrequencyVivacyDevice
Primary Outcome Measures
NameTimeMethod
Clinical examination by Sinclair scale3 months

Clinical

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath